FY2026 EPS Estimates for Amedisys Lifted by Leerink Partnrs

Amedisys, Inc. (NASDAQ:AMED - Free Report) - Analysts at Leerink Partnrs increased their FY2026 earnings per share estimates for Amedisys in a research note issued to investors on Wednesday, January 29th. Leerink Partnrs analyst W. Mayo now anticipates that the health services provider will post earnings of $5.06 per share for the year, up from their previous estimate of $4.53. The consensus estimate for Amedisys' current full-year earnings is $4.40 per share.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing analysts' consensus estimates of $1.19 by ($0.19). The firm had revenue of $587.67 million for the quarter, compared to the consensus estimate of $586.75 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The company's quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.98 earnings per share.

Amedisys Trading Down 0.5 %

Shares of AMED stock traded down $0.44 during mid-day trading on Monday, reaching $92.12. The stock had a trading volume of 319,386 shares, compared to its average volume of 298,299. The firm has a market capitalization of $3.02 billion, a PE ratio of 36.56, a price-to-earnings-growth ratio of 1.82 and a beta of 0.73. The stock's 50-day moving average price is $89.51 and its two-hundred day moving average price is $93.87. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys has a 52-week low of $82.15 and a 52-week high of $98.95.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Bank of Montreal Can grew its position in shares of Amedisys by 146.4% in the 2nd quarter. Bank of Montreal Can now owns 10,429 shares of the health services provider's stock worth $966,000 after buying an additional 6,197 shares during the last quarter. Algert Global LLC bought a new stake in Amedisys in the second quarter valued at $302,000. Creative Planning increased its position in Amedisys by 7.4% during the 2nd quarter. Creative Planning now owns 4,295 shares of the health services provider's stock valued at $394,000 after purchasing an additional 295 shares during the period. Cetera Investment Advisers raised its holdings in Amedisys by 26.5% in the 2nd quarter. Cetera Investment Advisers now owns 22,778 shares of the health services provider's stock worth $2,091,000 after purchasing an additional 4,773 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of Amedisys by 2,159.1% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 27,200 shares of the health services provider's stock worth $2,497,000 after purchasing an additional 25,996 shares during the period. Hedge funds and other institutional investors own 94.36% of the company's stock.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.